Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
IRCCS San Raffaele
University of Maryland, Baltimore
Medical University of Vienna
Tampere University Hospital
East Valley Hematology and Oncology Medical Group